- RETRACTION: Circular RNA-ZFR Inhibited Cell Proliferation and Promoted Apoptosis in Gastric Cancer by Sponging miR-130a/miR-107 and Modulating PTEN
-
Editors of Cancer Research and Treatment
- KMID: 2554359
- Cancer Res Treat.
- 2024 Apr;56(2):697-697.
- doi: 10.4143/crt.2017.537.RE
-
- CITED
-
- Close
- SHARE
-
- Close
- Prediction of Cancer Incidence and Mortality in Korea, 2024
-
Jung KW, Kang MJ, Park EH, Yun EH, Kim HJ, Kim JE, Kong HJ, Im JS, Seo HG
- KMID: 2554329
- Cancer Res Treat.
- 2024 Apr;56(2):372-379.
- doi: 10.4143/crt.2024.252
Purpose This study aimed to report the projected cancer incidence and mortality for the year 2024 to estimate Korea’s current cancer burden. Materials and Methods Cancer incidence data from 1999 to... -
- CITED
-
- Close
- SHARE
-
- Close
- Applicability of Spatial Technology in Cancer Research
-
Ahn S, Lee HS
- KMID: 2554327
- Cancer Res Treat.
- 2024 Apr;56(2):343-356.
- doi: 10.4143/crt.2023.1302
This review explores spatial mapping technologies in cancer research, highlighting their crucial role in understanding the complexities of the tumor microenvironment (TME). The TME, which is an intricate ecosystem of... -
- CITED
-
- Close
- SHARE
-
- Close
- Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2021
-
Park EH, Jung KW, Park NJ, Kang MJ, Yun EH, Kim HJ, Kim JE, Kong HJ, Im JS, Seo HG, The Community of Population-Based Regional Cancer Registries
- KMID: 2554328
- Cancer Res Treat.
- 2024 Apr;56(2):357-371.
- doi: 10.4143/crt.2024.253
Purpose The current study provides national cancer statistics and their secular trends in Korea, including incidence, mortality, survival, and prevalence in 2021. Materials and Methods Incidence, survival, and prevalence rates of... -
- CITED
-
- Close
- SHARE
-
- Close
- Health Inequities in Cancer Incidence According to Economic Status and Regions Are Still Existed Even under Universal Health Coverage System in Korea: A Nationwide Population Based Study Using the National Health Insurance Database
-
Chang Y, Hwang SH, Cho SA, Lee H, Cho E, Lee JY
- KMID: 2554330
- Cancer Res Treat.
- 2024 Apr;56(2):380-403.
- doi: 10.4143/crt.2023.650
Purpose The purpose of this study is to determine the level of health equity in relation to cancer incidence. Materials and Methods We used the National Health Insurance claims data of the National... -
- CITED
-
- Close
- SHARE
-
- Close
- Temporal Trend in Uptake of the National General Health Checkups and Cancer Screening Program among Korean Women with Breast Cancer
-
Tran TXM, Kim S, Cha C, Park B
- KMID: 2554341
- Cancer Res Treat.
- 2024 Apr;56(2):522-530.
- doi: 10.4143/crt.2023.729
Purpose This study assessed the temporal trends of uptake of national general health and cancer screening among women with breast cancer in Korea between 2009 and 2016. Materials and Methods We... -
- CITED
-
- Close
- SHARE
-
- Close
- Intrathoracic Progression Is Still the Most Dominant Failure Pattern after First-Line Chemo-immunotherapy in Extensive-Stage Small-Cell Lung Cancer: Implications for Thoracic Radiotherapy
-
Kim D, Kim HJ, Wu HG, Lee JH, Kim S, Kim TM, Kim JS, Kim BH
- KMID: 2554334
- Cancer Res Treat.
- 2024 Apr;56(2):430-441.
- doi: 10.4143/crt.2023.931
Purpose This study aimed to compare the failure patterns before and after the introduction of immunotherapy and to determine the role of thoracic radiotherapy (TRT) in extensive-stage small-cell lung cancer (ES-SCLC)... -
- CITED
-
- Close
- SHARE
-
- Close
- A Single-Arm Phase II Study of Nab-Paclitaxel Plus Gemcitabine and Cisplatin for Locally Advanced or Metastatic Biliary Tract Cancer
-
Liu T, Li Q, Lin Z, Liu C, Pu W, Zeng S, Lai J, Cai X, Zhang L, Wang S, Chen M, Cao W, Gou H, Zhu Q
- KMID: 2554349
- Cancer Res Treat.
- 2024 Apr;56(2):602-615.
- doi: 10.4143/crt.2023.726
Purpose Patients with advanced biliary tract cancer (BTC) have a poor survival. We aim to evaluate the efficacy and safety of nab-paclitaxel plus gemcitabine and cisplatin regimen in Chinese advanced... -
- CITED
-
- Close
- SHARE
-
- Close
- Physical Activity and Bladder Cancer Risk: Findings of the Japan Collaborative Cohort Study
-
An H, Liu K, Shirai K, Kawasaki R, Tamakoshi A, Iso H
- KMID: 2554350
- Cancer Res Treat.
- 2024 Apr;56(2):616-623.
- doi: 10.4143/crt.2023.962
Purpose The association of physical activity with the risk of bladder cancer remains inconsistent among Asian populations. We aimed to examine the association in a large Japanese cohort. Materials and Methods... -
- CITED
-
- Close
- SHARE
-
- Close
- Genomic Characteristics and Its Therapeutic Implications in Breast Cancer Patients with Detectable Molecular Residual Disease
-
Zhang S, Jiang Y, Zhou L, Xu J, Zhang G, Shen L, Xu Y
- KMID: 2554343
- Cancer Res Treat.
- 2024 Apr;56(2):538-548.
- doi: 10.4143/crt.2023.1059
Purpose Molecular residual disease (MRD) is the main cause of postoperative recurrence of breast cancer. However, the baseline tumor genomic characteristics and therapeutic implications of breast cancer patients with detectable MRD... -
- CITED
-
- Close
- SHARE
-
- Close
- Case Series of Soft Tissue Sarcoma Patients with Brain Metastasis with Implications from Genomic and Transcriptomic Analysis
-
Park C, Kim R, Choi J, Kim M, Kim TM, Han I, Kim JI, Kim HS
- KMID: 2554355
- Cancer Res Treat.
- 2024 Apr;56(2):665-674.
- doi: 10.4143/crt.2023.864
Purpose Brain metastasis rarely occurs in soft tissue sarcoma (STS). Here, we present five cases of STS with brain metastases with genetic profiles. Materials and Methods We included five patients from... -
- CITED
-
- Close
- SHARE
-
- Close
- Radiation Oncologists’ Perspectives on Oligometastatic Disease: A Korean Survey Study
-
Rim CH, Cho WK, Lee JH, Kim YS, Suh YG, Kim KH, Chang AR, Chie EK, Ahn YC, on behalf of the Oligometastasis Working Group, Korean Cancer Association
- KMID: 2554332
- Cancer Res Treat.
- 2024 Apr;56(2):414-421.
- doi: 10.4143/crt.2023.876
Purpose Perspectives of radiation oncologists on oligometastatic disease was investigated using multi-layered survey. Materials and Methods Online survey on the oligometastatic disease was distributed to the board-certified regular members of the... -
- CITED
-
- Close
- SHARE
-
- Close
- Assessment of Eligibility and Utilization of Accelerated Partial Breast Irradiation in Korean Breast Cancer Patients (KROG 22-15)
-
Chun SJ, Jo JH, Kim YB, Park S, Ahn SJ, Kim SS, Kim K, Shin KH
- KMID: 2554344
- Cancer Res Treat.
- 2024 Apr;56(2):549-556.
- doi: 10.4143/crt.2023.1109
Purpose We investigated the proportions of patients eligible for accelerated partial breast irradiation (APBI) among those with pT1-2N0 breast cancer, based on the criteria set by the American Society for Radiation... -
- CITED
-
- Close
- SHARE
-
- Close
- Implication of Pre- and Post-radiotherapy ctDNA Dynamics in Patients with Residual Triple-Negative Breast Cancer at Surgery after Neoadjuvant Chemotherapy: Findings from a Prospective Observational Study
-
Lee TH, Kim H, Kim YJ, Park WY, Park W, Cho WK, Kim N
- KMID: 2554342
- Cancer Res Treat.
- 2024 Apr;56(2):531-537.
- doi: 10.4143/crt.2023.996
Purpose This study aims to determine the association between pre- and postoperative radiotherapy (PORT) circulating tumor DNA (ctDNA) dynamics and oncological outcomes in patients with residual triple-negative breast cancer who underwent... -
- CITED
-
- Close
- SHARE
-
- Close
- Development of the Korean Association for Lung Cancer Clinical Practice Guidelines: Recommendations on Radial Probe Endobronchial Ultrasound for Diagnosing Lung Cancer - An Updated Meta-Analysis
-
Kim SH, Chung HS, Kim J, Kim MH, Lee MK, Kim I, Eom JS
- KMID: 2554337
- Cancer Res Treat.
- 2024 Apr;56(2):464-483.
- doi: 10.4143/crt.2023.749
Purpose Radial probe endobronchial ultrasound (RP-EBUS) accurately locates peripheral lung lesions (PLLs) during transbronchial biopsy (TBB). We performed an updated meta-analysis of the diagnostic yield of TBB for PLLs using... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Effect of Endosonography on Overall Survival in Patients with Radiological N1 Non–Small Cell Lung Cancer
-
Kim BG, Jeong BH, Park G, Kim HK, Shim YM, Shin SH, Lee K, Um SW, Kim H, Cho JH
- KMID: 2554339
- Cancer Res Treat.
- 2024 Apr;56(2):502-512.
- doi: 10.4143/crt.2023.840
Purpose It is unclear whether performing endosonography first in non–small cell lung cancer (NSCLC) patients with radiological N1 (rN1) has any advantages over surgery without nodal staging. We aimed to... -
- CITED
-
- Close
- SHARE
-
- Close
- A Phase 1b/2a Study of GC1118 with 5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in Patients with Recurrent or Metastatic Colorectal Cancer
-
Lee KW, Han SW, Kim TW, Ahn JB, Baek JY, Cho SH, Lee H, Kim JW, Kim JW, Kim TY, Hong YS, Beom SH, Cha Y, Choi Y, Kim S, Bang YJ
- KMID: 2554348
- Cancer Res Treat.
- 2024 Apr;56(2):590-601.
- doi: 10.4143/crt.2023.1117
Purpose GC1118 is a novel antibody targeting epidermal growth factor receptor (EGFR) with enhanced blocking activity against both low- and high-affinity EGFR ligands. A phase 1b/2a study was conducted to determine... -
- CITED
-
- Close
- SHARE
-
- Close
- Genomic Landscape of Pulmonary Sarcomatoid Carcinoma
-
Kwon HJ, Lee S, Han YB, Lee J, Kwon S, Kim H, Chung JH
- KMID: 2554335
- Cancer Res Treat.
- 2024 Apr;56(2):442-454.
- doi: 10.4143/crt.2023.764
Purpose Pulmonary sarcomatoid carcinoma (PSC) is a rare aggressive subtype of non–small cell lung cancer (NSCLC) with limited therapeutic strategies. We attempted to elucidate the evolutionary trajectories of PSC using... -
- CITED
-
- Close
- SHARE
-
- Close
- Tissue and Plasma-Based Highly Sensitive Blocker Displacement Amplicon Nanopore Sequencing for EGFR Mutations in Lung Cancer
-
Akkhasutthikun P, Kaewsapsak P, Nimsamer P, Klomkliew P, Visedthorn S, Chanchaem P, Teerapakpinyo C, Payungporn S, Luangdilok S
- KMID: 2554336
- Cancer Res Treat.
- 2024 Apr;56(2):455-463.
- doi: 10.4143/crt.2023.1108
Purpose The epidermal growth factor receptor (EGFR) mutation is a widely prevalent oncogene driver in non–small cell lung cancer (NSCLC) in East Asia. The detection of EGFR mutations is a... -
- CITED
-
- Close
- SHARE
-
- Close
- Pyrotinib Combined with Vinorelbine in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer: A Multicenter, Single-Arm, Prospective Study
-
Jiang K, Hong R, Xia W, Lu Q, Li L, Huang J, Shi Y, Yuan Z, Zheng Q, An X, Xue C, Huang J, Bi X, Chen M, Zhang J, Xu F, Wang S
- KMID: 2554340
- Cancer Res Treat.
- 2024 Apr;56(2):513-521.
- doi: 10.4143/crt.2023.786
Purpose This study aims to evaluate the efficacy and safety of a new combination treatment of vinorelbine and pyrotinib in human epidermal growth factor receptor 2 (HER2)–positive metastatic breast cancer... -
- CITED
-
- Close
- SHARE
-
- Close
